331 related articles for article (PubMed ID: 34439796)
21. Perillyl alcohol efficiently scavenges activity of cellular ROS and inhibits the translational expression of hypoxia-inducible factor-1α via mTOR/4E-BP1 signaling pathways.
Ma J; Li J; Wang KS; Mi C; Piao LX; Xu GH; Li X; Lee JJ; Jin X
Int Immunopharmacol; 2016 Oct; 39():1-9. PubMed ID: 27394002
[TBL] [Abstract][Full Text] [Related]
22. Reactive oxygen species and cancer paradox: To promote or to suppress?
Galadari S; Rahman A; Pallichankandy S; Thayyullathil F
Free Radic Biol Med; 2017 Mar; 104():144-164. PubMed ID: 28088622
[TBL] [Abstract][Full Text] [Related]
23. Ascorbic acid and its pro-oxidant activity as a therapy for tumours of oral cavity -- a systematic review.
Putchala MC; Ramani P; Sherlin HJ; Premkumar P; Natesan A
Arch Oral Biol; 2013 Jun; 58(6):563-74. PubMed ID: 23477602
[TBL] [Abstract][Full Text] [Related]
24. Ascorbic acid and ascorbate-2-phosphate decrease HIF activity and malignant properties of human melanoma cells.
Miles SL; Fischer AP; Joshi SJ; Niles RM
BMC Cancer; 2015 Nov; 15():867. PubMed ID: 26547841
[TBL] [Abstract][Full Text] [Related]
25. Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells.
Gong EY; Shin YJ; Hwang IY; Kim JH; Kim SM; Moon JH; Shin JS; Lee DH; Hur DY; Jin DH; Hong SW; Lee WK; Lee WJ
Toxicol Lett; 2016 Sep; 258():126-133. PubMed ID: 27339904
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic regulators: multifunctional proteins modulating hypoxia-inducible factor-α protein stability and activity.
Luo W; Wang Y
Cell Mol Life Sci; 2018 Mar; 75(6):1043-1056. PubMed ID: 29032501
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic strategies by modulating oxygen stress in cancer and inflammation.
Fang J; Seki T; Maeda H
Adv Drug Deliv Rev; 2009 Apr; 61(4):290-302. PubMed ID: 19249331
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticles of Waste Material of Propolis and Gelatin as a Novel System for Delivery of L-Ascorbic Acid.
Belloto de Francisco LM; Carrer Costa YT; Outuki PM; Souza RP; de Souza Bonfim Mendonca P; Novello CR; Lopes Consolaro ME; Bruschi ML
Curr Drug Deliv; 2017; 14(7):1028-1039. PubMed ID: 27067407
[TBL] [Abstract][Full Text] [Related]
29. Insight into the roles of vitamins C and D against cancer: Myth or truth?
Zhao CN; Li Y; Meng X; Li S; Liu Q; Tang GY; Gan RY; Li HB
Cancer Lett; 2018 Sep; 431():161-170. PubMed ID: 29857128
[TBL] [Abstract][Full Text] [Related]
30. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
Sen K; Banerjee S; Mandal M
Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
[TBL] [Abstract][Full Text] [Related]
31. Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer.
Kuiper C; Molenaar IG; Dachs GU; Currie MJ; Sykes PH; Vissers MC
Cancer Res; 2010 Jul; 70(14):5749-58. PubMed ID: 20570889
[TBL] [Abstract][Full Text] [Related]
32. Nanodrug constructed using dietary antioxidants for immunotherapy of metastatic tumors.
Wu X; Tan Y; Zhang J; Cui R; Liao C; Zhang S
J Mater Chem B; 2023 Mar; 11(13):2916-2926. PubMed ID: 36892505
[TBL] [Abstract][Full Text] [Related]
33. Studies of anticancer activity in vivo and in vitro behaviors of liposomes encapsulated iridium(III) complex.
Gu Y; Wen H; Zhang Y; Bai L; Zhou Y; Zhang H; Tian L; Hao J; Liu Y
J Biol Inorg Chem; 2021 Feb; 26(1):109-122. PubMed ID: 33475857
[TBL] [Abstract][Full Text] [Related]
34. Silver nanoparticles inhibit the function of hypoxia-inducible factor-1 and target genes: insight into the cytotoxicity and antiangiogenesis.
Yang T; Yao Q; Cao F; Liu Q; Liu B; Wang XH
Int J Nanomedicine; 2016; 11():6679-6692. PubMed ID: 27994464
[TBL] [Abstract][Full Text] [Related]
35. Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects.
Conklin KA
Nutr Cancer; 2000; 37(1):1-18. PubMed ID: 10965514
[TBL] [Abstract][Full Text] [Related]
36. Causes and Consequences of A Glutamine Induced Normoxic HIF1 Activity for the Tumor Metabolism.
Kappler M; Pabst U; Weinholdt C; Taubert H; Rot S; Kaune T; Kotrba J; Porsch M; Güttler A; Bache M; Krohn K; Bull F; Riemann A; Wickenhauser C; Seliger B; Schubert J; Al-Nawas B; Thews O; Grosse I; Vordermark D; Eckert AW
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554283
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of anti-cancer effects of ascorbate: Cytotoxic activity and epigenetic modulation.
Mastrangelo D; Pelosi E; Castelli G; Lo-Coco F; Testa U
Blood Cells Mol Dis; 2018 Mar; 69():57-64. PubMed ID: 28954710
[TBL] [Abstract][Full Text] [Related]
38. Role of hypoxia-inducible factor-1alpha as a cancer therapy target.
Patiar S; Harris AL
Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S61-75. PubMed ID: 17259560
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
Rohwer N; Cramer T
Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
[TBL] [Abstract][Full Text] [Related]
40. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
Martínez-Sánchez G; Giuliani A
J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
